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Introduction: Gastroesophageal Reflux Disease (GERD) is 
the most prevalent digestive disease of the modern society 
and has been associated with abnormalities in the larynx 
and pharynx (LPR). Nonetheless, little is known about the 
mechanisms involved in this atypical form of the disease. 
Contradictory clinical data suggest a defense deficit at this 
segment. Saliva with its organic and inorganic components 
is responsible for the homeostasis of the oral mucosa and 
the digestive tract. Salivary pH and volume abnormalities 
have been linked to laryngopharyngeal symptoms of GERD 
and LPR. In a recent study we demonstrated significant 
salivary pH reduction in patients with LPR. Another study 
found correlation between reduced salivary pH and volume 
directly related to esophageal pH-metry results. Aim: To 
evaluate salivary pH and volume before and after clinical 
treatment of LPR. Material and Method: Twenty-three adults 
with LPR had total fasting saliva tested before and after a 
12-week course of oral proton pump inhibitor. Results: A 
statistically significant difference was found in salivary pH 
before and after treatment with increase of pH values after 
control of the disease (p<0.001). Salivary volumes of treated 
patients were also significantly higher than in pre-treated 
patients (p=0.009). Discussion: These findings suggest that 
salivary pH and volume are influenced by the presence of 
gastroesophageal contents and that salivary pH monitoring 
can potentially become a cost-effective method for diagnosing 
and controlling LPR.





BRAZILIAN JOURNAL OF OTORHINOLARYNGOLOGY 72 (1) JANUARY/FEBRUARY 2006
http://www.rborl.org.br  /  e-mail: revista@aborlccf.org.br
INTRODUCTION
Gastroesophageal reflux (GER) is characterized 
by the spontaneous movement of the stomach gastric 
content to the esophagus. This reflux occurs daily in all 
human beings, being asymptomatic and without damage 
to the esophageal mucosa, thus considered physiologic. 
Notwithstanding, GER may cause great morbidity when 
it becomes symptomatic and causes lesions. Under these 
circumstances, it is known as Gastroesophageal reflux 
disease (GERD), being caused by a combination of reflux 
contact irritating factors (specially chloric acid and pepsin) 
with the mucosa and a deficiency in mucosal protection 
mechanisms. The Gastroesophageal Reflux Disease is 
considered the most prevalent gastrointestinal disease 
today. Reflux-related symptoms are reported weekly by 
3 to 6% of the general population1-9. Multicentric studies 
with large numbers of people have shown how this disease 
may manifest in a silent or a multisymtomatic way from 
the digestive stand point7-9. Notwithstanding, its symptoms 
cause important drops in the individual’s life quality7. It 
is believed that this great prevalence is due to a combina-
tion of a number of factors, from bad feeding habits and 
obesity10,11 all the way down to genetic factors9.
In the last 12 years, many investigators and clinicians 
have proposed an association between Gastroesophageal 
Reflux Disease (GERD) and chronic laryngitis, the later 
representing the clinical form of the disease called Laryn-
gopharyngeal Reflux (LPR)1-4,8,12-30. The larynx findings in 
cases of reflux laryngitis vary according to the case sever-
ity, it goes from hyperemia and mild edema of the larynx 
posterior third to severe cases of contact ulcers in the 
vocal process, exuberant scar tissue, larynx lining altera-
tions, subglotic stenosis, even neoplastic degeneration of 
the epithelium14,31,32.
According to some authors, estimates as to acid re-
flux causing posterior laryngitis vary greatly, coming up to 
80% of the cases14,33. This causal relationship has increased 
thanks to the technological development of devices capa-
ble of measuring the proximal and distal stomach acidity 
and that of the pharynx13,21,34-40, we also have optic fibers 
which are broadly used in clinical practice, and they do 
facilitate viewing the larynx19,20. We still do not know, ex-
actly, how many reflux episodes are necessary to produce 
inflammatory changes and larynx lesions. Notwithstanding, 
studies such as the ones from Delahunty & Cherry in 196841 
and Koufman in 199114 showed that the attack of chloric 
acid and pepsin on the laryngeal mucosa of dogs caused 
contact granulomas in the first study, and subglotic stenosis 
in the second study, after some weeks. The role of non-acid 
substances, such as bile and pancreatic secretions, in caus-
ing larynx lesions is still controversial because we still lack 
broadly available techniques to clinically measure it33,42. It 
is interesting to notice how a large number of laryngopha-
ryngeal reflux patients, even those with the most dramatic 
larynx findings, do not have esophagitis or other signs of 
GERD in their digestive tract8,25,29. Of course, the gastric 
and esophageal mucosas protection mechanisms play a 
decisive role in the capacity these organs have to withstand 
daily mechanical and chemical aggressions, and many of 
these mechanisms are saliva mediated31-32,45-48. Saliva has 
many organic and inorganic substances that contribute to 
the protection against physical and chemical aggression 
and also to maintain mucosal integrity, not only of the oral 
cavity, but also of the digestive tract43,45,46,48-52.
We then set sail, based on the following assump-
tions:
• The esophageal-salivary reflex increases salivary 
production (both qualitatively and quantitatively), with a 
consequent increase in its presence within the esophagus, 
when there is any mechanical stimulation in this organ43, 
as is the case with laryngopharyngeal reflux. Thus, there 
is a greater availability of organic and inorganic salivary 
substances in the esophagus, besides the salivary volume 
itself that, together contribute to dilute and neutralize the 
refluxed contents43,45,46,48.
• Recent studies in patients with LPR have shown 
a reduction in the salivary pH of these patients when 
compared to normal individuals without the disease25,31,53,54. 
It was also noticed that there is a positive correlation 
between the presence of laryngopharyngeal symptoms 
and a reduction both in volume and in saliva pH in LPR 
patients53, it is possible to establish a correlation between 
the presence of esophageal reflux measured through 24h 
esophageal pHmetry and this reduction in salivary volume 
and pH54.
• Recent population studies show that over 30% of 
the general population present occasional laryngopharyn-
geal symptoms related to gastroesophageal reflux and up 
to 40% of these individuals have normal endoscopic exam 
of their digestive mucosa8. These findings point towards 
the GERD silent behavior, but also lead us to infer that 
there may possibly be more factors involved in the GERD 
physiopathology than only the gastroduodenal reflux, be-
ing acid or alkaline.
LPR is known as a risk factor for the development 
of a number of laryngopharyngeal mucosa alterations, and 
the most severe is the neoplastic degeneration14.
Despite the progress in understanding GERD and 
LPR, there are still many unanswered questions, specially 
in regards to the latter. We still do not know why patients 
with the same degree of proximal gastric reflux (to the 
larynx and pharynx) present manifestations and clinical 
findings of such different magnitude. Could it be some 
local larynx and pharynx mucosa protection factor that 
could be deficient or simply did not exist, making cer-
tain individuals so sensitive to this reflux? Eckley’s study 
(2002)25 suggests that there is, in fact, a deficit of epider-
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mal growth factor (EGF) in the salivary secretion, such 
substance is produced by the salivary glands, besides a 
significant alteration in the salivary pH of individuals with 
chronic laryngitis due to LPR, when compared to their 
normal counterparts. Notwithstanding, we do not know 
if these salivary alterations, both quantitative and qualita-
tive, are innate or if they develop along one’s life span. 
We also do not know if controlling GERD and LPR allow 
for a balancing on these salivary alterations. 
Our goal with this study is to assess both the sali-
vary volume and pH in LPR individuals before and after 
controlling the disease in order to establish whether the 
previously seen deficit is primary or secondary. 
MATERIALS AND METHODS
We studied 19 individuals with clinical videolaryn-
goscopy LPR diagnosis corroborated by a positive two 
channel 24 hour esophageal pHmetry. The participants in 
the study answered a detailed questionnaire about their 
general health and GERD-related symptoms, its digestive 
and otolaryngological consequences. All the study partici-
pants were examined by means of a flexible nasofibroscope 
according to previously established protocol 25, done right 
at the beginning of the study (pre-treatment exam) and 
after clinical treatment (post-treatment exam). 
The 19 participants in the study had two total spon-
taneous saliva sample collected in the morning after a 12 
hour fasting period, one in the pre-treatment phase and 
another in post treatment. The patients were instructed 
not to use toothpaste on the harvesting day, which was 
carried out according the following technique:
Harvesting of Total Spontaneous Saliva
After rinsing the mouth with plain water to flush 
away epithelial scaling and bacterial remains, the patient 
remained seated, without swallowing saliva for a period 
of 15 minutes. This saliva would then run to the corner of 
the mouth (the subject should also avoid bringing nasal 
material into his/her mouth) into a glass funnel, linked 
to a test tube. 
Saliva processing
Total saliva was centrifuged for 10 minutes in room 
temperature at a speed of 5,000-7,000 revolutions per 
minute (rpm) in order to sediment bacteria, epithelial cells, 
nucleus remains and other debris. The supernatant was 
collected with a pipette and transferred to an ml graded 
Falcon tube in order to measure volume and pH. The 
samples were alpha-numerically labeled. 
Measuring Saliva Volume
In order to determine saliva volume, we used su-
pernatant saliva, free from debris and foam. Measurement 
was carried out through the Falcon test tube grading itself, 
and volume was recorded in ml.
Measuring Saliva pH
Salivary pH (supernatant saliva previously processed 
by the aforementioned technique) was digitally measured 
through a digital pH sensor (Denver Instrument Company, 
Model: Basic pH-meter; Arvada, CO, USA). We initially 
calibrated the device using buffered solutions with pH 
4.0 and pH 7.0. after that the sensor probe was dipped in 
saliva filled Falcon tube, where it remained for 30 seconds, 
thus yielding automatic pH reading. 
LPR Treatment
Treatment was initially clinical and standardized for 
all patients, being: 
Omeprazole 20mg per os before breakfast and 20mg 
per os after dinner for 12 (twelve) weeks.
After this time, the patients were reassessed from the 
stand point of clinical symptoms and laryngoscopic signs 
of LPR. Those who presented clinical control of symptoms 
and of the laryngitis signs had their saliva harvested7 days 
after medication interruption. We compared both the sa-
liva volume and pH before and after treatment, as well as 
the correlation of symptoms relief and larynx inflamma-
tory findings. Results were put in a table and statistically 
analyzed. 
Inclusion Criteria:
We only included in the study those patients that 
had videolaryngoscopy diagnosis of LPR corroborated by 
two channel 24h esophageal pHmetry, who consented 
their participation after being fully informed about our 
goals, procedures used and risks involved. 
Exclusion Criteria:
Exclusion factors were: smoking, alcohol drinking 
and exposure to abrasive chemical inhalants, because all 
these factors cause respiratory mucosa inflammation, thus 
mimicking the changes found in the GERD. Besides, we 
also excluded the patients who had used gastric secretion 
blocking agents, pro-kinetic, anti-acids or hormonal and 
non-hormonal anti-inflammatory agents in the 7 days pre-
ceding salivary harvesting, because of the influence these 
drugs have on the digestive tract mucosa and in gastric 
secretion. We also excluded patients with pre-neoplastic 
or neoplastic lesions of the pharynx and larynx (present 
or previously treated). Individuals with omeprazole intol-
erance were excluded, as well as those patients who did 
not present disease control after the established treatment 
period for this study. 
RESULTS
A total of 19 patients were eligible to participate in 
the study, 14 women and 5 men, with average age of 43.7 
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Table 1. Clinical, laryngoscopic and salivary data from the participants 
in the study.












1 F 56 MOD 7,29 9,5 7,68 9,5
2 F 60 MOD 6,98 6,5 7,79 9
3 M 46 MOD 6,87 9 7,67 12
4 F 47 MOD 6,95 8 7,48 12
5 M 24 MOD 7,25 8,5 7,88 9
6 F 19 MOD 6,95 4,5 7,78 7
7 F 41 MOD 7,29 6 7,69 7,5
8 M 43 MOD 7,12 7 7,52 7,5
9 F 36 MOD 7,76 1 7,89 3,5
10 F 50 MOD 7,42 9,5 7,6 4
11 F 21 MOD 6,98 6 7,45 7
12 F 44 MOD 6,64 9 7,88 9,5
13 F 56 MOD 7,25 5,5 7,74 6
14 F 47 MOD 7,29 10,5 7,69 12
15 F 50 MOD 7,51 5,5 7,83 6
16 F 48 MOD 7,11 3,5 7,54 5
17 F 48 MOD 7,35 10 7,63 12
18 M 46 MOD 7,2 10 7,53 10
19 M 48 MOD 6,65 5 7,36 5,5
20 F 47 MOD 6,76 8,5 7,78 6,5
21 F 72 MOD 7,16 7 7,92 6
22 F 56 MOD 6,3 9,5 7,51 17
23 F 41 MOD 7,27 11,5 7,84 13
Figure 1. Falcon graded test tube with saliva supernatant.  Salivary pH 
digital measuring method demonstration.
Figure 2. Salivary pH values pre and post treatment and LPR clinical 
control.
Figure 3. Pre and post treatment Salivary volume values and LPR 
clinical control.
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years, ranging from 19 to 56 years. All had videolaryngos-
copy suggestive signs of moderate degree LPR31.
The average pre-treatment salivary pH of the group 
was 7.15 and post-treatment was 7.58, statistically signifi-
cant difference (p<0.05). Average pre-treatment salivary 
volume was of 7.07ml comparing to a value of 8.02ml post-
treatment – there was no statistically significant difference 
between the samples, although we did see a trend towards 
an increase in salivary volume after treatment (Table 1).
There was no statistical correlation between salivary 
pH or volume related to gender, age or intensity of com-
plaints, either laryngopharyngeal or digestive. 
When we compared salivary pH values of the in-
dividuals with LPR with those from the pre-established 
group of normal individuals25, we noticed that even having 
a significant increase in values after disease treatment and 
control, salivary pH remained below the average of that 
from the normal individuals (p=0.04).
All patients tolerated well the proposed treatment, 
without side effects. 
DISCUSSION AND CONCLUSIONS 
The few studies in the world medical literature men-
tion qualitative and quantitative changes in the saliva of 
patients with GERD DRGE45,46,48,55,56 and LPR31,32,54, but did 
not ascertain whether these alterations were congenital 
or acquired. These and other studies indicate that the la-
ryngeal mucosa is very sensitive to gastroduodenal reflux, 
and suggest that LPR, even when intermittent, may cause 
severe larynx inflammatory lesions1,30. Notwithstanding, so 
far we were unable to establish the factors that influence 
the intensity of symptoms with the laryngoscopic findings, 
and were also unable to explain the lack of compatibil-
ity of such findings. Salivary studies in these individuals 
have shown new horizons in understanding LPR physi-
opathology, suggesting that there are both qualitative and 
quantitative saliva deficits25,31,32,53,54.
The results from the current study suggest that both 
LPR treatment and clinical control allow for a reduction 
in salivary acidity, or better, an alkalinization closer to 
physiological levels, because adult saliva pH is of about 
8, and in LPR individuals it is closer to 7.0-7.5. Despite the 
small size sample in this study (which is still ongoing), 
we believe that there is global salivary deficit, possibly 
primary in LPR individuals, as we have proven in previ-
ous studies of volume, pH and organic substances such 
as epidermal growth. 
The salivary pH study offers a less invasive way to 
assess local acidity, it is fast and of low cost. 
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